tallózása szerző szerint "Schmid KW"

1-3 / 3

Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.

Szarvas, Tibor; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky, Ilona; Rubben H (2014)

In this study, we assessed the changes and prognostic relevance of syndecan-1 (SDC1) tissue and serum levels in bladder cancer (BC). SDC1 levels were analyzed in 213 samples (119 paraffin-embedded and 79 serum samples of ...
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.

Tschirdewahn S; Reis H; Niedworok C; Nyirády Péter; Szendrői Attila; Schmid KW; Shariat SF; Kramer G; Vom Dorp F; Rubben H; Szarvas T (2014)

OBJECTIVES: YKL-40 is a novel inflammatory serum protein shown to be associated with the presence and prognosis of several malignancies. However, its prognostic relevance has not yet been analyzed in bladder cancer (BC). ...
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancer.

Szarvas, Tibor; Reis H; Vom Dorp F; Tschirdewahn S; Niedworok C; Nyirády, Péter; Schmid KW; Rubben H; Kovalszky, Ilona (2016)

BACKGROUND: PSA-screening detects many cases of clinically non-aggressive prostate cancer (PC) leading to significant overtreatment. Therefore, pre-operatively available prognostic biomarkers are needed to help therapy ...

1-3 / 3

Keresés